Inlroduction
Leukotriene D4 (LTD4) has been shown to be the major biological activity of slow-reacting substance of anaphylaxis (SRS-A) when measured on guineapig ileum Morris, Taylor, Rokach, Girard, Piper, Tippins & Samhoun, 1980) . LTD4 is probably formed from LTC4 by -y-glutamyltranspeptidase (Orning & Hammarstr6m, 1980) and these leukotrienes have biological actions that are very similar to those of slowreacting substance of anaphylaxis. However, there are differences in potency and duration of action between LTC4 and LTD4 in some systems (Piper, Samhoun, Tippins, Williams, Palmer & Peck, 1981; Letts & Piper, 1981) . In addition to LTD4, perfusates from guinea-pig lung collected during anaphylaxis contained appreciable amounts of another leukotriene, LTB4 (Morris, Taylor, Piper & Tippins, 1979) which, unlike LTC4 and LTD4, lacks the peptide side chain at C-6 (Radmark, Malmsten, Samuelsson, Clark, Goto, Marfat & Corey, 1980) . Slow-reacting substance of anaphylaxis and bradykinin (Bk) are potent bronchoconstrictor agents in guinea pig in vivo. Furthermore, both SRS-Aand Bk-induced bronchoconstriction in this species is inhibited by aspirin-like drugs (Collier, Holgate, Schachter & Shorley, 1960; Berry & Collier, 1964) . Since non-steroid anti-inflammatory drugs inhibit prostaglandin synthesis (Vane, 1971) , this suggests that cyclo-oxygenase products of arachidonic acid (AA) metabolism have a role in the airways constriction due to SRS-A and bradykinin. Further, both SRS-A and Bk release rabbit aorta-contracting substance (RCS) from guinea-pig isolated perfused lungs (Piper & Vane, 1969) . The release of RCS is inhibited by aspirin (Palmer, Piper & Vane, 1973) and glucocorticoids (Engineer, Morris, Piper & Sirois, 1978) . The major component of RCS has been shown to be the unstable AA metabolite, thromboxane A2 (TxA2) (Ti 30-40s at 37°C) which causes constriction of arteries, airway smooth muscle and platelet aggregation (Svensson, Hamberg & Samuelsson, 1975; Samuelsson, 1976; Svensson, Strandberg, Tuvemo & Hamberg, 1977) . In this paper, the arterial smooth muscle-contracting material (Ti <60s, 37°C) released from guinea-pig lung by various agonists will be referred to as thromboxane 0007-1188/82/100267-09 $01.00 A2. Like SRS-A, LTC4 and LTD4 release cyclooxygenase products from guinea-pig isolated perfused lung and contract guinea-pig parenchyma: both actions are blocked by indomethacin . Although LTB4 has little effect on gastrointestinal or vascular smooth muscle, it contracts guinea-pig parenchyma and these contractions are also inhibited by indomethacin (Sirois, Borgeat, Jeanson, Roy & Girard, 1980) .
The purpose of the investigations described in this paper was to assess the contribution of TxA2 to the actions of the leukotrienes in guinea-pig perfused lungs and parenchyma in vitro. Since the Bk-induced release of cyclo-oxygenase products from guinea-pig lung is also inhibited by mepacrine (Vargaftig & Dao Hai, 1972) , we have investigated the effect of mepacrine on the mechanism of release of TxA2 by leukotrienes.
Methods
Male guinea-pigs (Dunkin-Hartley) weighing 500-700 g were used, and their lungs and ilea were excised after cervical dislocation. Other assay tissues were obtained from male rabbits (New Zealand White strain, 3-3.5 kg) and male rats (Wistar strain, 250-300 g).
Isolatedperfused lungs and assay tissues
Lungs were inflated via the trachea and perfused free from blood with oxygenated Tyrode solution (5 ml/min) at 37°C via the pulmonary artery. Lung effluent superfused a series of assay tissues sensitive to cyclo-oxygenase products and to LTC4 and LTD4 (SRS-A). The tissues were strips of: rabbit aorta (RbA), rabbit mesenteric artery (RbMA), rat stomach (RSS) and sometimes guinea-pig ileum smooth muscle (GPISM). They were superfused continuously with mepyramine (0.1 lg/ml), hyoscine (0.1 gLg/ml), methysergide (0.2 tLg/ml), phenoxybenzamine (0.1 Lg/ml) and propranolol (2 jtg/ml) (Piper & Vane, 1969) .
Lungparenchymal strips
Lungs were perfused free from blood as described above, and sections of parenchyma were prepared by a modification of the method of Lulich, Mitchell & Sparrow (1976 (Wasserman, 1976) and has TxA2-like actions on smooth muscle preparations, was used as a standard agonist to test the sensitivity of the assay tissues.
Mepacrine: Mepacrine did not affect RbA, RbMa or RSS but altered the sensitivity of GPISM. Doseresponse curves to SRS-A, AA and Bk given intraarterially were therefore obtained in the absence of mepacrine. Mepacrine was then infused intraarterially for 10-15 min and the lung effluent directed away from the assay tissues which in the meantime were superfused with mepacrine-free Tyrode. At the end of the infusion of mepacrine, the lung effluent was again superfused over the assay tissues and the different doses of agonists were then re-tested.
Parenchymal strips: LTB4, LTC4, LTD4 and Bk were administered as bolus injections (10-1001 l) into the fluid superfusing the guinea-pig parenchymal strips (GPPs). In all experiments, U-44069 was used as a standard agonist to test the sensitivity of the parenchymal strips. To prevent tachyphylaxis from occurring doses of LTB4 were always alternated with doses of other agonists. Actions of agonists were studied before and after administration of antagonists and inhibitors.
FPL55712: FPL55712 was superfused over the parenchymal strips for 10 min before and then continuously during re-testing of LTB4, LTC4, LTD4 and Bk.
Imidazole, carboxyheptylimidazole and mepacrine:
Parenchymal strips were superfused with either im- arterially into isolated perfused lungs inhibited the dose-related contractions of RbA and RbMA and greatly reduced those of RSS induced by i.a. administrations of SRS-A (0.2-1.0 u, the equivalent of 2-lOpmol of LTD4). The.effect of mepacrine was reversible because 35min after termination of the mepacrine infusion, RbA, RbMA and RSS contracted, indicating that the release of TxA2 and prostaglandin-like materials from the lungs had completely returned (n = 4). The direct effect of SRS-A was measured on GPISM which was included in the superfusion cascade system. Contractions of GPISM to SRS-A given intra-arterially throughout the experiment were much smaller than those due to doses administered directly, showing loss of biological activity of SRS-A during passage through the pulmonary vascular bed. SRS-A administered directly over the tissues did not contract the arterial tissues but produced small contractions of the RSS. Typical results obtained on RbA and GPISM are shown in Figure 2 . At the same doses of SRS-A, similar results were obtained with mepacrine at 400 pM (n = 3).
However, at this higher concentration, mepacrine increased the spontaneous activity of GPISM. No inhibition of SRS-A-induced release of cyclooxygenase products was seen with mepacrine at 100 pM(n = 3). (derived from PMNs) and LTD4 (both administered at 1-30pmol) but not those due to U-44069 (0.3-3.0 nmol). Contractions of GPPs due to 10 pmol of LTB4 and LTD4 were reduced by 78.5±8.2% and 72.7±4.6% respectively. LTD4 produced dose-related contractions of GPISM which FIgure 4 Effect of imidazole (2.9 mM) on responses of strips of guinea-pig parenchyma (GPP) and guinea-pig ileum smooth muscle (GPISM) induced by leukotriene B4 (LTB4), LTD4 (both at 10 and 30 pmol) and U-44069 (3 nmol). Imidazole (at arrow) superfused over the tissues considerably reduced the contractions of GPP due to the LTs but not those to U-44069. Contractions of GPISM due to LTD4 were not inhibited by imidazole. Vertical scale: mV. Horizontal scale: 10 min.
1-10 pmol), imidazole inhibited the leukotrieneinduced contractions of GPPs by 70-95% (n = 5 in all cases). Contractions elicited by 5 pmol of LTC4 and LTD4 were reduced by 81.7±3.1% and 84.2 ± 2.1% respectively. . Typical results using LTB4 and LTC4 are shown in Figure 6 .
This inhibition was slowly reversible and 90 min after termination of mepacrine infusion, a 50% recovery of contractions of GPPs to the leukotrienes was observed (n = 6-12).
Discussion
The experiments described in this paper show that, like SRS-A, LTB4, LTC4 and LTD4 stimulate arachidonic acid metabolism in isolated guinea-pig lung and parenchymal strips. This action of SRS-A and the leukotrienes is reversibly inhibited by mepacrine, a phospholipase inhibitor, which has no effect on the generation of TxA2 and prostaglandin-like materials induced by exogenous AA from isolated perfused lungs. This suggests that, by supplying the lung with the substrate (i.e. AA), TxA2 and prostaglandin synthesis can occur independently of a phospholipase. However, in the case of SRS-A and the leukotrienes stimulation of phospholipase is an essential step for the subsequent release of endogenous AA and generation of TxA2.
Inhibition by mepacrine of the Bk-induced release of cyclo-oxygenase products from isolated perfused lungs suggests that Bk also exerts its action via activation of phospholipase (as previously described by Vargaftig & Dao Hai (1972) ).
Further evidence for the stimulation of phospholipase by SRS-A can be inferred from studies describing the inhibition of the effect of SRS-A in guinea-pig isolated perfused lung by glucocorticoids (Engineer et al., 1978) . These results can now be explained by the steroid-induced synthesis and release of macrocortin which inhibits phospholipase A2 and the subsequent release of TxA2 and prostaglandins (Blackwell, Camuccio, Di Rosa, Flower, Parente & Persico, 1980) , imidazole, a thromboxane synthetase inhibitor, greatly reduces by the same extent release of TxA2 induced by either LTC4 or LTD4 from guinea-pig isolated perfused lung. Using radioimmunoassay of mono-O-methyl-TxB2, other workers have also demonstrated the release of TxA2 from guinea-pig perfused lung by LTC4 and shown it to be antagonized by FPL 55712 (Berti, Folco & Omini, 1981) .
Contractions of parenchymal strips elicited by LTB4, LTC4 and LTD4 are also greatly inhibited by imidazole and carboxyheptylimidazole which is a very potent and specific inhibitor of thromboxane synthetase (Lewis & Watts, 1982) . In the guinea-pig, parenchymal strips (in vitro preparations of peripheral airways) are more sensitive to LTC4 and LTD4 than larger airways such as the isolated trachea which could be due to thromboxanes being mainly synthesized in the parenchyma while the tracheal tissue produces mainly prostaglandinlike materials (Gryglewski, Dembinska-Kiec, Grodzinska & Panczenko, 1976) . These results suggest that LTB4, LTC4 and LTD4 exert their action in parenchymal strips mainly via generation of the potent bronchoconstrictor, TxA2. However, there are differences between LTB4 and leukotrienes C4 and D4 in the biological systems described in this paper. Unlike the peptidolipid leukotrienes, LTB4 does not contract guinea-pig ileum, which suggests that the amino-acid residue at C-6 is a prerequisite for contraction of this tissue.
In parenchymal strips, tachyphylaxis occurs after repeated administration of LTB4 but not after LTC4 or LTD4. Furthermore, FPL55712, the SRS-A antagonist, has no effect on contractions of parenchymal strips induced by LTB4 (as in the case of Bk) but antagonizes those due to LTC4 and LTD4. In conclusion, the results suggest that at the doses used LTB4, LTC4 and LTD4 stimulate AA metabolism leading to generation of TxA2 in guinea-pig lung in vitro but that LTB4 acts on different receptors from those activated by the peptidolipid leukotrienes.
